Amneal Pharmaceuticals, Inc. SEC filings AMRX
Amneal Pharmaceuticals, Inc. has 694 filings in SEC EDGAR's recent list, going back to Nov 21, 2017. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K/A | Amended current report | Oct 23, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Sep 21, 2026 | Sep 17, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 11, 2026 |
| S-3ASR | Automatic shelf registration | Sep 3, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 14, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 12, 2026 | — |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 12, 2026 | Aug 10, 2026 |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 31, 2026 | Jul 31, 2026 |
| DEFA14A | Additional proxy material | Jul 30, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| DEFM14A | Filing | Jun 29, 2026 | — |
| PREM14A | Filing | Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 11, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 27, 2026 | — |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Apr 22, 2026 | Apr 22, 2026 |
| 4/A | Form 4/a | Mar 27, 2026 | Mar 2, 2026 |
| 4/A | Form 4/a | Mar 27, 2026 | Mar 2, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 26, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| DEFA14A | Additional proxy material | Mar 25, 2026 | — |
| DEF 14A | Proxy statement | Mar 25, 2026 | May 6, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 3, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 28, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| 4 | Insider transaction | Nov 14, 2025 | Nov 12, 2025 |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 7, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 6, 2025 | — |
| 4 | Insider transaction | Aug 28, 2025 | Aug 27, 2025 |
| 144 | Notice of proposed sale | Aug 27, 2025 | — |
| 4 | Insider transaction | Aug 25, 2025 | Aug 22, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 144 | Notice of proposed sale | Aug 14, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 12, 2025 |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jul 21, 2025 | Jul 16, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 16, 2025 |
| 144 | Notice of proposed sale | May 16, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 12, 2025 |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 2, 2025 | May 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| DEFA14A | Additional proxy material | Mar 25, 2025 | — |
| DEF 14A | Proxy statement | Mar 25, 2025 | May 6, 2025 |
| 4 | Insider transaction | Mar 17, 2025 | Mar 14, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 17, 2025 | — |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 144 | Notice of proposed sale | Mar 5, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Mar 1, 2025 |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 28, 2025 | Feb 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 23, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 8, 2025 |
| 4 | Insider transaction | Jan 6, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 21, 2024 |
| 144 | Notice of proposed sale | Nov 22, 2024 | — |
| 144 | Notice of proposed sale | Nov 21, 2024 | — |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K/A |
Amended current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2024 | Sep 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 31, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 144 | Notice of proposed sale | Aug 14, 2024 | — |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
| 4 | Insider transaction | May 14, 2024 | May 10, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRX (Nasdaq)
- Fiscal year ends
- December 31
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1723128
- Former names
- Atlas Holdings, Inc. (until Apr 13, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.